
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Belizean Mahogany Nuts contain mahagonin (MSC15), a key bioactive compound demonstrating potent antidiabetic activity by inhibiting PTP-1B protein. This inhibition, observed through in silico studies, suggests a mechanism similar to glibenclamide.

Reported Benefits (Provisional)
Origin & History

The Belizean Mahogany Nut (Swietenia macrophylla) is derived from the majestic mahogany tree, native to the tropical forests of Belize. It thrives in well-drained, fertile soils with a warm, humid climate, producing seeds traditionally valued for their nutritional and medicinal properties.
Research Narrative (Provisional)
Scientific studies document Belizean Mahogany Nuts for their potential cardiovascular health benefits, brain function support, and anti-inflammatory effects. Research highlights their rich content of unsaturated fats and antioxidants, aligning with traditional uses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Unsaturated Fats (Monounsaturated and Polyunsaturated) - Essential Fatty Acids - Vitamins: Vitamin E - Phytochemicals: Antioxidants
Reported Mechanism (Provisional)
The primary antidiabetic mechanism involves mahagonin (MSC15) acting as a potent inhibitor of PTP-1B protein, which is an established therapeutic target for type 2 diabetes. In silico molecular docking studies show mahagonin binds to PTP-1B with a strong binding energy of -8.86 kcal/mol, forming hydrogen bonds at critical residues like GLU276, ASN193, and LYS197. Beyond PTP-1B inhibition, other compounds like flavonoids, phenols, and catechin/epicatechin contribute to antioxidant, anti-inflammatory, and neuroprotective activities by modulating various cellular pathways.
Clinical Narrative (Provisional)
Current research on Belizean Mahogany Nuts primarily consists of in silico molecular docking studies and pre-clinical investigations, identifying potential antidiabetic, antioxidant, antimicrobial, and anticancer effects. For instance, computational models have demonstrated mahagonin's strong binding affinity to PTP-1B protein, suggesting its antidiabetic potential. While these studies highlight promising bioactivity, robust human clinical trials are currently lacking to establish efficacy, optimal dosages, and long-term health outcomes in human populations. Further research is needed to validate these preliminary findings clinically.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







